Cytotoxicity in vitro of preleukaemic lymphoid cells on syngeneic monolayers of embryo or thymus cells

Por Wahren, Britta, Metcalf, Donald
Publicado em 1970

Bone Marrow Colony-stimulating Activity of Sera in Infectious Mononucleosis

Por Metcalf, D., Wahren, Britta
Publicado em 1968

DNA Vaccines: Recent Developments and the Future

Por Wahren, Britta, Liu, Margaret A.
Publicado no Vaccines (Basel) (2014)

Sequence Variation within Three Important Cytomegalovirus Gene Regions in Isolates from Four Different Patient Populations

Por Zweygberg Wirgart, Benita, Brytting, Maria, Linde, Annika, Wahren, Britta, Grillner, Lena
Publicado em 1998

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity

Por Boberg, Andreas, Stålnacke, Alexandra, Bråve, Andreas, Hinkula, Jorma, Wahren, Britta, Carlin, Nils
Publicado no ISRN Mol Biol (2012)

Short Communication: HIV-1 Nef Protein Carries Multiple Epitopes Suitable for Induction of Cellular Immunity for an HIV Vaccine in Africa

Por Kilpeläinen, Athina, Axelsson Robertson, Rebecca, Leitner, Thomas, Sandström, Eric, Maeurer, Markus, Wahren, Britta
Publicado em 2014

Immunization with HIV protease peptides linked to syngeneic erythrocytes

Por Boberg, Andreas, Dominici, Sabrina, Brave, Andreas, Hallermalm, Kristian, Hinkula, Jorma, Magnani, Mauro, Wahren, Britta
Publicado em 2007

Comparison of Plasmid Vaccine Immunization Schedules Using Intradermal In Vivo Electroporation

Por Hallengärd, David, Haller, B. Kristian, Maltais, Anna-Karin, Gelius, Eva, Nihlmark, Kopek, Wahren, Britta, Bråve, Andreas
Publicado em 2011

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines

Por Hallengärd, David, Bråve, Andreas, Isaguliants, Maria, Blomberg, Pontus, Enger, Jenny, Stout, Richard, King, Alan, Wahren, Britta
Publicado em 2012

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

Por Andäng, Michael, Hinkula, Jorma, Hotchkiss, Graham, Larsson, Sten, Britton, Sven, Wong-Staal, Flossie, Wahren, Britta, Ährlund-Richter, Lars
Publicado em 1999

Strong HIV-Specific CD4(+) and CD8(+) T-Lymphocyte Proliferative Responses in Healthy Individuals Immunized with an HIV-1 DNA Vaccine and Boosted with Recombinant Modified Vaccinia...

Por Aboud, Said, Nilsson, Charlotta, Karlén, Katarina, Marovich, Mary, Wahren, Britta, Sandström, Eric, Gaines, Hans, Biberfeld, Gunnel, Godoy-Ramirez, Karina
Publicado em 2010

Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput Method To Monitor the Humoral Immune Response again...

Por Cosma, Antonio, Bühler, Silja, Nagaraj, Rashmi, Staib, Caroline, Hammarin, Anna-Lena, Wahren, Britta, Goebel, Frank D., Erfle, Volker, Sutter, Gerd
Publicado em 2004

Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment

Por Roos, Anna-Karin, Eriksson, Fredrik, Timmons, James A., Gerhardt, Josefine, Nyman, Ulrika, Gudmundsdotter, Lindvi, Bråve, Andreas, Wahren, Britta, Pisa, Pavel
Publicado em 2009

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness

Por Nowroozalizadeh, Salma, Gudmundsdotter, Lindvi, Hejdeman, Bo, Andersson, Lena, Esbjörnsson, Joakim, Medstrand, Patrik, Sandström, Eric, Gaines, Hans, Wahren, Britta, Jansson, Marianne
Publicado em 2013

Cross-Reactive T-Helper Responses in Patients Infected with Different Subtypes of Human Immunodeficiency Virus Type 1

Por Leandersson, Ann-Charlotte, Gilljam, Gustav, Fredriksson, Malin, Hinkula, Jorma, Alaeus, Annette, Lidman, Knut, Albert, Jan, Bratt, Göran, Sandström, Eric, Wahren, Britta
Publicado em 2000

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

Por Elmén, Joacim, Thonberg, Håkan, Ljungberg, Karl, Frieden, Miriam, Westergaard, Majken, Xu, Yunhe, Wahren, Britta, Liang, Zicai, Ørum, Henrik, Koch, Troels, Wahlestedt, Claes
Publicado em 2005

Potent cellular and humoral immunity against HIV-1 elicited in mice by a DNA-prime/MVA-boost vaccine regimen intended for human use

Por Wahren, Britta, Bråve, Andreas, Boberg, Andreas, Rollman, Erik, Birx, Deborah, Cox, Josephine, Robb, Merlin, Moss, Bernhard, Blomberg, Pontus, Biberfeldt, Gunnel, Sandström, Eric
Publicado em 2006

A Novel Class of Anti-HIV Agents with Multiple Copies of Enfuvirtide Enhances Inhibition of Viral Replication and Cellular Transmission In Vitro

Por Chang, Chien-Hsing, Hinkula, Jorma, Loo, Meiyu, Falkeborn, Tina, Li, Rongxiu, Cardillo, Thomas M., Rossi, Edmund A., Goldenberg, David M., Wahren, Britta
Publicado em 2012

Immunogenicity of HIV Virus-Like Particles in Rhesus Macaques by Intranasal Administration

Por Buonaguro, Luigi, Tagliamonte, Maria, Visciano, Maria Luisa, Andersen, Hanne, Lewis, Mark, Pal, Ranajit, Tornesello, Maria Lina, Schroeder, Ulf, Hinkula, Jorma, Wahren, Britta, Buonaguro, Franco M.
Publicado em 2012

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

Por Gudmundsdotter, Lindvi, Nilsson, Charlotta, Brave, Andreas, Hejdeman, Bo, Earl, Patricia, Moss, Bernard, Robb, Merlin, Cox, Josephine, Michael, Nelson, Marovich, Mary, Biberfeld, Gunnel, Sandström, Eric, Wahren, Britta
Publicado no Vaccine (2009)